Roy Daniel Pollom, MD

Pharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.

Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.